BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Multiple myeloma (MM) is a haematologic malignancy characterized by the presence of atypical plasma cells. Basigin (BSG, CD147) controls lactate export through the monocarboxylic acid transporter 1 (MCT1, SLC16A1) and supports MM survival and proliferation. Additionally, BSG is implicated in response to treatment with immunomodulatory drugs (thalid...
Alternative Titles
Full title
BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5977166
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5977166
Other Identifiers
ISSN
2073-4425
E-ISSN
2073-4425
DOI
10.3390/genes9050226
